These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 9519872

  • 1. Oncogenic potential of a mutant human thyrotropin receptor expressed in FRTL-5 cells.
    Fournes B, Monier R, Michiels F, Milgrom E, Misrahi M, Feunteun J.
    Oncogene; 1998 Feb 26; 16(8):985-90. PubMed ID: 9519872
    [Abstract] [Full Text] [Related]

  • 2. Role of the cAMP and MAPK pathways in the transformation of mouse 3T3 fibroblasts by a TSHR gene constitutively activated by point mutation.
    Du Villard JA, Wicker R, Crespo P, Russo D, Filetti S, Gutkind JS, Sarasin A, Suárez HG.
    Oncogene; 2000 Oct 05; 19(42):4896-905. PubMed ID: 11039907
    [Abstract] [Full Text] [Related]

  • 3. Mutations in the mouse TSH receptor equivalent to human constitutively activating TSH receptor mutations also cause constitutive activity.
    Neumann S, Krohn K, Chey S, Paschke R.
    Horm Metab Res; 2001 May 05; 33(5):263-9. PubMed ID: 11440271
    [Abstract] [Full Text] [Related]

  • 4. Contrasting effects of activating mutations of GalphaS and the thyrotropin receptor on proliferation and differentiation of thyroid follicular cells.
    Ludgate M, Gire V, Crisp M, Ajjan R, Weetman A, Ivan M, Wynford-Thomas D.
    Oncogene; 1999 Aug 26; 18(34):4798-807. PubMed ID: 10490813
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative proteomic analysis to dissect differences in signal transduction in activating TSH receptor mutations in the thyroid.
    Krause K, Boisnard A, Ihling C, Ludgate M, Eszlinger M, Krohn K, Sinz A, Fuhrer D.
    Int J Biochem Cell Biol; 2012 Feb 26; 44(2):290-301. PubMed ID: 22074661
    [Abstract] [Full Text] [Related]

  • 11. Single strand DNA-binding proteins and thyroid transcription factor-1 conjointly regulate thyrotropin receptor gene expression.
    Shimura H, Shimura Y, Ohmori M, Ikuyama S, Kohn LD.
    Mol Endocrinol; 1995 May 26; 9(5):527-39. PubMed ID: 7565801
    [Abstract] [Full Text] [Related]

  • 12. Dissociation of thyrotropin receptor function and thyrotropin dependency in rat thyroid tumour cell lines derived from FRTL-5.
    van der Kallen CJ, Coes JH, van Grafhorst JP, Schuuring EM, Ossendorp FA, Thijssen JH, Blankenstein MA, de Bruin TW.
    Br J Cancer; 1996 Aug 26; 74(4):606-12. PubMed ID: 8761378
    [Abstract] [Full Text] [Related]

  • 13. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas.
    Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J, Vassart G.
    Nature; 1993 Oct 14; 365(6447):649-51. PubMed ID: 8413627
    [Abstract] [Full Text] [Related]

  • 14. [Transfection of follicular thyroid gland carcinoma cells with human TSH receptor changes growth, invasion and adhesion].
    Hoelting T, Duh QY, Clark OH, Herfarth C.
    Langenbecks Arch Chir Suppl Kongressbd; 1998 Oct 14; 115(Suppl I):281-4. PubMed ID: 14518260
    [Abstract] [Full Text] [Related]

  • 15. Induction of specific phosphodiesterase isoforms by constitutive activation of the cAMP pathway in autonomous thyroid adenomas.
    Persani L, Lania A, Alberti L, Romoli R, Mantovani G, Filetti S, Spada A, Conti M.
    J Clin Endocrinol Metab; 2000 Aug 14; 85(8):2872-8. PubMed ID: 10946896
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Biological activity of activating thyrotrophin receptor mutants: modulation by iodide.
    Al-Khafaji F, Wiltshire M, Fuhrer D, Mazziotti G, Lewis MD, Smith PJ, Ludgate M.
    J Mol Endocrinol; 2005 Feb 14; 34(1):209-20. PubMed ID: 15691889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.